PURE Bioscience, Inc. (PURE.OB) reported that its third-quarter net loss was $1.5 million or $0.14 per share, an improvement from a net loss of $1.8 million or $0.31 per share in the same quarter last year.
Loss from operations decreased $200,000 to $1.6 million, compared to a loss from operations of $1.8 million in the same year-ago quarter.
Total operating costs and expenses decreased $200,000 to $1.8 million, compared to $2.0 million in the same year-ago quarter. The decrease was primarily due to a decrease in legal fees, travel, non-cash stock option expense, and depreciation and amortization expense.
Net product sales rose to $258,000, from last year's $207,000. The increase was primarily attributable to increased sales to two existing customers.
For comments and feedback: editorial@rttnews.com